Skip to main content

Year: 2022

Frontera Records First Revenue with FY2022 Annual Filing

Uplisting to Senior Exchange Planned DALLAS, TEXAS, Oct. 10, 2022 (GLOBE NEWSWIRE) — Frontera Group, Inc. (OTC Pink: FRTG) (“Frontera” or “the Company”), a technology-focused strategic acquirer of revenue-generating companies and intellectual property (IP), today announced that it has filed its annual 10K financial statement for FY2022 with the Securities and Exchange Commission. The filing may be viewed at https://www.sec.gov/ix?doc=/Archives/edgar/data/1602813/000154972722000089/frtg-10k.htm. “For the first time in our history, in the last quarter, Frontera recorded revenues from royalties related to the IP we acquired from Intellimedia,” said Andrew De Luna, CPA, MBA, Interim Chief Financial Officer of Frontera Group. “This milestone represents a significant validation of our ‘’buy and build’ growth strategy, and we expect to...

Continue reading

When a Picture is Worth Thousands: ACV Virtual Lift™ Now Offers Dealers a Solution to Combat Increasing Catalytic Converter Thefts

Full-length panoramic imagery, coupled with machine learning capabilities, offers bottom line protection when acquiring inventory BUFFALO, N.Y., Oct. 10, 2022 (GLOBE NEWSWIRE) — ACV (Nasdaq: ACVA), the leading digital automotive marketplace and data services partner for dealers and commercial partners, further empowers dealers to make informed buying decisions with its latest advancement in artificial intelligence and a solution that detects, with extremely high accuracy, the presence of catalytic converters. ACV’s Virtual Lift™ provides dealers with a clear and accurate view of the vehicle’s undercarriage, ensuring an unobscured view of the exhaust system. The company’s machine learning capability now offers an added layer of confidence to the buying process with detection algorithms that confirm the presence or absence of catalytic...

Continue reading

HII Announces Mentor-Protégé Joint Venture with Markesman Group to Accelerate Next-Generation Cybersecurity Solutions

Tuple logo Tuple logoMCLEAN, Va., Oct. 10, 2022 (GLOBE NEWSWIRE) — HII (NYSE: HII) announced today the formation of Tuple, a mentor-protégé joint venture with Markesman Group. Together, HII and Markesman form a unified team to accelerate next-generation cybersecurity solutions for the defense marketplace.   Tuple was formed under the U.S. Small Business Administration mentor-protégé program, which allows eligible small businesses to gain capacity and win government contracts by partnering with more experienced government contractors like HII, which serve as mentors. The Tuple joint venture will leverage HII’s information warfare domain and Markesman Group’s unique cyber operations expertise to support the Department of Defense’s cyber mission as it pertains to force transformation and multi-domain operations. Combined capability...

Continue reading

Vantiva: Information concerning the total number of voting rights and shares

October 10th, 2022 Vantiva: Information concerning the total number of voting rights and shares, provided pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des marchés financiersVantiva Shares(ISIN Code FR0013505062)Date Number of Outstanding Shares Number of Voting RightsSeptember 30, 2022   355,343,245   Number of Theoretical Voting Rights(1): 355,343,245Number of Voting Rights Exercisable at Shareholders’ meeting(2): 355,343,245(1)    Calculated, pursuant to Article 223-11 of the General Regulations of the Autorité des Marchés Financiers, based on the total number of outstanding shares to which voting rights are attached, including shares with suspended voting rights. (2)    Excluding shares with suspended voting rights. *                ** About...

Continue reading

Zealand Pharma major shareholder announcement: Van Herk Investments

Company announcement – No. 46 / 2022 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark and Boston, MA, 10 October 2022 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces the receipt of notification dated 10 October 2022 pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders: As from 7 October 2022 Van Herk Investments B.V. (Dutch registration no. 59055057) holds nominally 7,630,244 shares (each share carrying one vote) in Zealand Pharma A/S, corresponding to 14,81% of the total share capital and total voting rights Zealand Pharma A/S. Van Herk Investments B.V. is 100% owned by Van Herk Investments THI B.V....

Continue reading

Smart City Platforms Market to Grow $258.2 Billion By 2026 – Report by MarketsandMarkets™

Chicago, Oct. 10, 2022 (GLOBE NEWSWIRE) — The global Smart City Platforms Market size to grow from USD 156.1 billion in 2021 to USD 258.2 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 10.6 % during the forecast period , according to a new report by MarketsandMarkets™. Various factors such as increase in adoption of IoT technology for infrastructure management and city monitoring and exponential rise in urban population are expected to drive the adoption of smart city platforms solutions and services. Smart city platforms offer a middleware operational capability, wherein multiple software and hardware can be integrated, along with several communication protocols, to deliver latent-free solutions for smart cities. Smart city platforms provide a common level of abstraction and manage information from multiple smart...

Continue reading

Dry Eye Disease Market to Hit sales of $8.21 Billion by 2028 | Allergen, Johnson and Johnson, and Novartis, Takeda, and Sun Pharmaceutical Hold 35% Market Share

Global Dry Eye Disease Market size was valued at US$ 5.95 billion in 2021, and it is expected to reach a value of US$ 8.21 billion by 2028, at a CAGR of more than 4.71% over the forecast period (2022- 2028). Westford,USA, Oct. 10, 2022 (GLOBE NEWSWIRE) — As the population ages, the prevalence of dry eye disease (DED) is expected to increase. As per recent study, the disease affects the around 5.5% to 33% global population every year.  But, it is highly prominent in people above 45% years, especially in women across the Global Dry Eye Disease Market. The condition is already the most common reason for visits to eye care professionals, and this trend is likely to continue as the baby boomer generation enters its golden years. There are a number of factors that contribute to the development of DED, including medications, skin diseases,...

Continue reading

Medical Products Market to Hit Sales $716.28 Billion by 2028 | Trends, Challenges and Opportunity | SkyQuest Technology

Global Medical Products Market size was valued at USD 508.2 billion in 2021 and is expected to reach USD 716.28 billion by 2028, growing at a CAGR of 6.76% during the forecast period 2022-2028). Westford,USA, Oct. 10, 2022 (GLOBE NEWSWIRE) — Global Medical Products Market is highly competitive, with a large number of small and medium-sized companies vying for market share. In order to succeed, companies need to focus on product innovation and providing value to their customers. They also need to have a clear understanding of the regulatory landscape and be able to navigate the complex approval process for new products. According to SkyQuest, the top 10 medical product manufacturing companies in global medical products market are Johnson & Johnson, GE Healthcare, Philips, Siemens Healthineers, Medtronic, Abbott Laboratories,...

Continue reading

Boskalis and partners renew Europa Terminal in the port of Antwerp

PSA terminal 4 PSA terminal 4Papendrecht, 10 October 2022 Boskalis, together with partners Artes Roegiers, Artes Depret and Herbosch-Kiere, will renew the Europa Terminal in Antwerp, Belgium for client Port of Antwerp-Bruges to ensure that the port can continue to receive the largest container ships and increase capacity by a third. The work, which officially commenced last Friday, will take nine years and will be carried out in three phases, taking maximum account of nature and the environment. The project carries a total value of EUR 335 million. Global container congestion calls for more efficient space for handling containers for larger ships. For this reason, the current draft of ships that can moor at the quay wall of the Europa Terminal will be deepened from 13.5 meters to the maximum draft of approximately 16 meters. As the...

Continue reading

REC Silicon – Presentation at the UEDA Conference

October 10, 2022: REC Silicon ASA (REC Silicon) Please find attached the company presentation given by Kurt Levens, REC Silicon CEO, at the UEDA conference in Bozeman, Montana, USA. For further information, please contact: Nils O. Kjerstad IR Contact Phone: +47 9135 6659 Email: nils.kjerstad@crux.no About REC Silicon REC Silicon is a leading producer of advanced silicon materials, delivering high-purity polysilicon and silicon gas to the solar and electronics industries worldwide. We combine 30 years of experience and proprietary technology with the needs of our customers, and annual production capacity of more than 20,000 MT of polysilicon from our two US-based manufacturing plants. Listed on the Oslo Stock Exchange (ticker: REC), the company is headquartered in Fornebu, Norway. For more information, go to: www.recsilicon.com...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.